Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

(2019) Renato D. Lopes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of direct oral anticoagulants on left ventricular thrombus

(2019) Özge Turgay Yıldırım et al.   BLOOD COAGULATION & FIBRINOLYSIS

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

(2019) Pascal Vranckx et al.   LANCET

DIRECT ORAL ANTICOAGULANTS COMPARED TO WARFARIN FOR LEFT VENTRICULAR THROMBI: A SINGLE CENTER EXPERIENCE

(2018) Austin Robinson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus

(2018) Aloysius Sheng-Ting Leow et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Efficacy of Direct Acting Oral Anticoagulant Drugs in Treatment of Left Atrial Appendage Thrombus in Patients with Atrial Fibrillation

(2018) Adam Fleddermann et al.   AMERICAN JOURNAL OF CARDIOLOGY

TREATMENT OF LEFT VENTRICULAR THROMBUS USING WARFARIN VERSUS DIRECT ORAL ANTICOAGULANTS FOLLOWING ANTERIOR MYOCARDIAL INFARCTION

(2018) A. Jaidka et al.   CANADIAN JOURNAL OF CARDIOLOGY

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

(2018) Faiez Zannad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease

(2018) Caroline Sindet-Pedersen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

(2017) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

(2017) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study

(2017) Vilhelm Sjögren et al.   PLoS One

Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)

(2016) Gregory Y.H. Lip et al.   AMERICAN HEART JOURNAL

36 Triple Therapy Anticoagulation following Percutaneous Coronary Intervention (PCI) with Novel Oral Anticoagulants (NOAC) is Safe and has no Adverse Effects on Bleeding Post Procedure when Compared to Triple Therapy with Vitamin K Antagonist (VKA)

(2016) Reshma Amin et al.   HEART

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

(2016) C. Michael Gibson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Echocardiographic Algorithm for Post–Myocardial Infarction LV Thrombus

(2016) Jonathan W. Weinsaft et al.   JACC-Cardiovascular Imaging

Incidence and Predictors of Early Left Ventricular Thrombus After ST-Elevation Myocardial Infarction in the Contemporary Era of Primary Percutaneous Coronary Intervention

(2014) Silvia Gianstefani et al.   AMERICAN JOURNAL OF CARDIOLOGY

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm

(2012) Shunichi Homma et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure

(2009) Barry M. Massie et al.   CIRCULATION

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE